牛牛AI助理已提取核心訊息
On February 27, 2024, 3M Company, through its wholly owned subsidiary Solventum Corporation, successfully issued a series of senior notes totaling $6.9 billion with varying maturities ranging from 2027 to 2064. The issuance was part of a strategic financing plan to facilitate the proposed distribution of at least 80.1% of Solventum's common stock to 3M's shareholders, known as the Spin-Off. The senior notes, which were sold in private placements to qualified institutional buyers, are guaranteed by 3M until the completion of the Spin-Off, after which the guarantee will terminate. Solventum plans to use the net proceeds from the note offerings to make cash payments to 3M as partial consideration for the transfer of its health care business to Solventum, ensuring Solventum retains $600 million in cash post-Spin-Off. The notes were not initially registered under the Securities Act or any state securities laws, and a Registration Rights Agreement was entered into to facilitate a future exchange offer for the notes.
On February 27, 2024, 3M Company, through its wholly owned subsidiary Solventum Corporation, successfully issued a series of senior notes totaling $6.9 billion with varying maturities ranging from 2027 to 2064. The issuance was part of a strategic financing plan to facilitate the proposed distribution of at least 80.1% of Solventum's common stock to 3M's shareholders, known as the Spin-Off. The senior notes, which were sold in private placements to qualified institutional buyers, are guaranteed by 3M until the completion of the Spin-Off, after which the guarantee will terminate. Solventum plans to use the net proceeds from the note offerings to make cash payments to 3M as partial consideration for the transfer of its health care business to Solventum, ensuring Solventum retains $600 million in cash post-Spin-Off. The notes were not initially registered under the Securities Act or any state securities laws, and a Registration Rights Agreement was entered into to facilitate a future exchange offer for the notes.
2024年2月27日，3M公司通過其全資子公司Solventum Corporation成功發行了一系列總額爲69億美元的優先票據，期限從2027年到2064年不等。此次發行是戰略融資計劃的一部分，該計劃旨在促進向3M股東分配Solventum至少80.1％的普通股的提議，即分拆計劃。優先票據以私募方式出售給合格的機構買家，在分拆完成之前由3M擔保，此後擔保將終止。Solventum計劃使用票據發行的淨收益向3M支付現金，作爲將其醫療保健業務轉讓給Solventum的部分對價，從而確保Solventum在分拆後保留6億美元的現金。這些票據最初不是根據《證券法》或任何州證券法註冊的，因此簽訂了註冊權協議，以促進這些票據的未來交易所要約。
2024年2月27日，3M公司通過其全資子公司Solventum Corporation成功發行了一系列總額爲69億美元的優先票據，期限從2027年到2064年不等。此次發行是戰略融資計劃的一部分，該計劃旨在促進向3M股東分配Solventum至少80.1％的普通股的提議，即分拆計劃。優先票據以私募方式出售給合格的機構買家，在分拆完成之前由3M擔保，此後擔保將終止。Solventum計劃使用票據發行的淨收益向3M支付現金，作爲將其醫療保健業務轉讓給Solventum的部分對價，從而確保Solventum在分拆後保留6億美元的現金。這些票據最初不是根據《證券法》或任何州證券法註冊的，因此簽訂了註冊權協議，以促進這些票據的未來交易所要約。
有用
沒用